Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes

References

• Sowa ME, Bennett EJ, Gygi SP, Harper JW. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009; 138:389 - 403; http://dx.doi.org/10.1016/j.cell.2009.04.042; PMID: 19615732
   PubMed Web of Science ®Google Scholar
• Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005; 123:773 - 86; http://dx.doi.org/10.1016/j.cell.2005.11.007; PMID: 16325574
   PubMed Web of Science ®Google Scholar
• Wilkinson KD. DUBs at a glance. J Cell Sci 2009; 122:2325 - 9; http://dx.doi.org/10.1242/jcs.041046; PMID: 19571111
   PubMed Web of Science ®Google Scholar
• Hussain S, Zhang Y, Galardy PJ. DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors. Cell Cycle 2009; 8:1688 - 97; http://dx.doi.org/10.4161/cc.8.11.8739; PMID: 19448430
   PubMed Web of Science ®Google Scholar
• Luise C, Capra M, Donzelli M, Mazzarol G, Jodice MG, Nuciforo P, et al. An atlas of altered expression of deubiquitinating enzymes in human cancer. PLoS One 2011; 6:e15891; http://dx.doi.org/10.1371/journal.pone.0015891; PMID: 21283576
   PubMed Web of Science ®Google Scholar
• Fang Y, Fu D, Shen XZ. The potential role of ubiquitin c-terminal hydrolases in oncogenesis. Biochim Biophys Acta 2010; 1806:1 - 6; PMID: 20302916
   PubMed Web of Science ®Google Scholar
• Colland F. The therapeutic potential of deubiquitinating enzyme inhibitors. Biochem Soc Trans 2010; 38:137 - 43; http://dx.doi.org/10.1042/BST0380137; PMID: 20074048
   PubMed Web of Science ®Google Scholar
• Atanassov BS, Koutelou E, Dent SY. The role of deubiquitinating enzymes in chromatin regulation. FEBS Lett 2010; PMID: 20974139
   PubMed Web of Science ®Google Scholar
• Guédat P, Colland F. Patented small molecule inhibitors in the ubiquitin proteasome system. BMC Biochem 2007; 8:Suppl 1 S14; http://dx.doi.org/10.1186/1471-2091-8-S1-S14; PMID: 18047738
   PubMedGoogle Scholar
• Hybrigenics SA; WO2007017758 (2007)
   Google Scholar
• Colland F, Formstecher E, Jacq X, Reverdy C, Planquette C, Conrath S, et al. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol Cancer Ther 2009; 8:2286 - 95; http://dx.doi.org/10.1158/1535-7163.MCT-09-0097; PMID: 19671755
   PubMed Web of Science ®Google Scholar
• Novartis AG; WO2007009715 (2007)
   Google Scholar
• Borodovsky A, Kessler BM, Casagrande R, Overkleeft HS, Wilkinson KD, Ploegh HL. A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J 2001; 20:5187 - 96; http://dx.doi.org/10.1093/emboj/20.18.5187; PMID: 11566882
   PubMed Web of Science ®Google Scholar
• Hershko A, Rose IA. Ubiquitin-aldehyde: a general inhibitor of ubiquitin-recycling processes. Proc Natl Acad Sci U S A 1987; 84:1829 - 33; http://dx.doi.org/10.1073/pnas.84.7.1829; PMID: 3031653
   PubMed Web of Science ®Google Scholar
• Mullally JE, Moos PJ, Edes K, Fitzpatrick FA. Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway. J Biol Chem 2001; 276:30366 - 73; http://dx.doi.org/10.1074/jbc.M102198200; PMID: 11390388
   PubMed Web of Science ®Google Scholar
• Mullally JE, Fitzpatrick FA. Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death. Mol Pharmacol 2002; 62:351 - 8; http://dx.doi.org/10.1124/mol.62.2.351; PMID: 12130688
   PubMed Web of Science ®Google Scholar
• Kapuria V, Peterson LF, Fang D, Bornmann WG, Talpaz M, Donato NJ. Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. Cancer Res 2010; 70:9265 - 76; http://dx.doi.org/10.1158/0008-5472.CAN-10-1530; PMID: 21045142
   PubMed Web of Science ®Google Scholar
• Bazzaro M, Anchoori RK, Mudiam MK, Issaenko O, Kumar S, Karanam B, et al. α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells. J Med Chem 2011; 54:449 - 56; http://dx.doi.org/10.1021/jm100589p; PMID: 21186794
   PubMed Web of Science ®Google Scholar
• Achanta G, Modzelewska A, Feng L, Khan SR, Huang P. A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome. Mol Pharmacol 2006; 70:426 - 33; PMID: 16636137
   PubMed Web of Science ®Google Scholar
• Amerik AYu, Swaminathan S, Krantz BA, Wilkinson KD, Hochstrasser M. In vivo disassembly of free polyubiquitin chains by yeast Ubp14 modulates rates of protein degradation by the proteasome. EMBO J 1997; 16:4826 - 38; http://dx.doi.org/10.1093/emboj/16.16.4826; PMID: 9305625
   PubMed Web of Science ®Google Scholar
• Luker GD, Pica CM, Song J, Luker KE, Piwnica-Worms D. Imaging 26S proteasome activity and inhibition in living mice. Nat Med 2003; 9:969 - 73; http://dx.doi.org/10.1038/nm894; PMID: 12819780
   PubMed Web of Science ®Google Scholar
• Stack JH, Whitney M, Rodems SM, Pollok BA. A ubiquitin-based tagging system for controlled modulation of protein stability. Nat Biotechnol 2000; 18:1298 - 302; http://dx.doi.org/10.1038/82422; PMID: 11101811
   PubMed Web of Science ®Google Scholar
• Papa FR, Hochstrasser M. The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene. Nature 1993; 366:313 - 9; http://dx.doi.org/10.1038/366313a0; PMID: 8247125
   PubMed Web of Science ®Google Scholar
• Li T, Naqvi NI, Yang H, Teo TS. Identification of a 26S proteasome-associated UCH in fission yeast. Biochem Biophys Res Commun 2000; 272:270 - 5; http://dx.doi.org/10.1006/bbrc.2000.2767; PMID: 10872838
   PubMed Web of Science ®Google Scholar
• Li Z, Melandri F, Berdo I, Jansen M, Hunter L, Wright S, et al. Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. Biochem Biophys Res Commun 2004; 319:1171 - 80; http://dx.doi.org/10.1016/j.bbrc.2004.05.098; PMID: 15194490
   PubMed Web of Science ®Google Scholar
• Dayal S, Sparks A, Jacob J, Allende-Vega N, Lane DP, Saville MK. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53. J Biol Chem 2009; 284:5030 - 41; http://dx.doi.org/10.1074/jbc.M805871200; PMID: 19098288
   PubMed Web of Science ®Google Scholar
• Westermarck J. Regulation of transcription factor function by targeted protein degradation: an overview focusing on p53, c-Myc, and c-Jun. Methods Mol Biol 2010; 647:31 - 6; http://dx.doi.org/10.1007/978-1-60761-738-9_2; PMID: 20694659
   PubMedGoogle Scholar
• Shan J, Zhao W, Gu W. Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol Cell 2009; 36:469 - 76; http://dx.doi.org/10.1016/j.molcel.2009.10.018; PMID: 19917254
   PubMed Web of Science ®Google Scholar
• Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 2010; 29:405 - 34; http://dx.doi.org/10.1007/s10555-010-9235-2; PMID: 20737283
   PubMed Web of Science ®Google Scholar
• Yang H, Landis-Piwowar KR, Chen D, Milacic V, Dou QP. Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Curr Protein Pept Sci 2008; 9:227 - 39; http://dx.doi.org/10.2174/138920308784533998; PMID: 18537678
   PubMed Web of Science ®Google Scholar
• Milacic V, Banerjee S, Landis-Piwowar KR, Sarkar FH, Majumdar AP, Dou QP. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res 2008; 68:7283 - 92; http://dx.doi.org/10.1158/0008-5472.CAN-07-6246; PMID: 18794115
   PubMed Web of Science ®Google Scholar
• Dikshit P, Goswami A, Mishra A, Chatterjee M, Jana NR. Curcumin induces stress response, neurite outgrowth and prevent NF-kappaB activation by inhibiting the proteasome function. Neurotox Res 2006; 9:29 - 37; http://dx.doi.org/10.1007/BF03033305; PMID: 16464750
   PubMed Web of Science ®Google Scholar
• Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?. AAPS J 2009; 11:495 - 510; http://dx.doi.org/10.1208/s12248-009-9128-x; PMID: 19590964
   PubMed Web of Science ®Google Scholar
• Si X, Wang Y, Wong J, Zhang J, McManus BM, Luo H. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J Virol 2007; 81:3142 - 50; http://dx.doi.org/10.1128/JVI.02028-06; PMID: 17229707
   PubMed Web of Science ®Google Scholar
• Straus DS, Glass CK. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 2001; 21:185 - 210; http://dx.doi.org/10.1002/med.1006; PMID: 11301410
   PubMed Web of Science ®Google Scholar
• Yadav VR, Prasad S, Sung B, Aggarwal BB. The role of chalcones in suppression of NF-κB-mediated inflammation and cancer. Int Immunopharmacol 2011; 11:295 - 309; http://dx.doi.org/10.1016/j.intimp.2010.12.006; PMID: 21184860
   PubMed Web of Science ®Google Scholar
• Becker K, Marchenko ND, Palacios G, Moll UM. A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model. Cell Cycle 2008; 7:1205 - 13; http://dx.doi.org/10.4161/cc.7.9.5756; PMID: 18418047
   PubMed Web of Science ®Google Scholar
• Lu Y, Adegoke OA, Nepveu A, Nakayama KI, Bedard N, Cheng D, et al. USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1. Mol Cell Biol 2009; 29:547 - 58; http://dx.doi.org/10.1128/MCB.00329-08; PMID: 19015242
   PubMed Web of Science ®Google Scholar
• McFarlane C, Kelvin AA, de la Vega M, Govender U, Scott CJ, Burrows JF, et al. The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. Cancer Res 2010; 70:3329 - 39; http://dx.doi.org/10.1158/0008-5472.CAN-09-4152; PMID: 20388806
   PubMed Web of Science ®Google Scholar
• Li S, Sonenberg N, Gingras AC, Peterson M, Avdulov S, Polunovsky VA, et al. Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency. Mol Cell Biol 2002; 22:2853 - 61; http://dx.doi.org/10.1128/MCB.22.8.2853-2861.2002; PMID: 11909977
   PubMed Web of Science ®Google Scholar